CRISPR Therapeutics Market by Technology Type (CRISPR-Cas9 Gene Editing, Base Editing, Prime Editing, CRISPR Interference and Activation and Epigenome Editing), Application (Hemoglobinopathies, Oncology, Infectious Diseases, Metabolic Disorders and Ophthalmic Disorders), and End User (Hospitals and Specialty Clinics, Academic and Research Institutions and Pharmaceutical and Biotechnology Companies) and Forecast 2034
$3,000.00
Report Specifications
The CRISPR therapeutics market covers gene-editing products, clinical development programs, and enabling platform technologies that use clustered regularly interspaced short palindromic repeats systems to modify disease-causing genetic sequences in human cells. These approaches span laboratory-engineered cell therapies and direct in vivo editing candidates designed to correct, disrupt, or regulate genes underlying inherited and acquired conditions. As a transformative treatment modality, CRISPR-based medicine holds the potential to deliver one-time, durable outcomes for patients with few therapeutic alternatives.
Report emphasis rests on the clinical and commercial progression of programmable gene-editing medicines from laboratory validation toward approved, reimbursable therapy. Specialized treatment infrastructure, careful patient selection, and long-term follow-up define how these novel medicines are delivered in routine practice. The prospect of single-course genetic treatment is reshaping expectations for lifelong disease management, while regulatory, manufacturing, and safety considerations govern the pace at which editing platforms reach everyday care.
The global CRISPR therapeutics market research report provides market size (USD million, 2024 to 2034), market share analysis, growth trends and forecast (CAGR%, 2026 to 2034).
The global CRISPR therapeutics market is segmented by technology type (CRISPR-Cas9 gene editing, base editing, prime editing, CRISPR interference and activation and epigenome editing), application (hemoglobinopathies, oncology, infectious diseases, metabolic disorders and ophthalmic disorders), and end user (hospitals and specialty clinics, academic and research institutions and pharmaceutical and biotechnology companies), and geography.
The global CRISPR therapeutics market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.
In addition, the global CRISPR therapeutics market report provides detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market through company overview, financial snapshots, major products, technologies, services offered and recent developments.
Major players operating in the global CRISPR therapeutics market and profiled in this report include CRISPR Therapeutics AG, Editas Medicine, Inc., Intellia Therapeutics, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Mammoth Biosciences, Inc., Vertex Pharmaceuticals Incorporated, Novartis AG, Regeneron Pharmaceuticals, Inc., and Eli Lilly and Company.
DATA INCLUDED: CRISPR Therapeutics Market Size, CRISPR Therapeutics Market Share, CRISPR Therapeutics Market Growth Rates, CRISPR Therapeutics Market Trends, and CRISPR Therapeutics Market Forecast to 2034
Market Data:
- Base Year Estimation: 2025
- Historical Data Range: 2024-2025
- Forecast Period: 2026-2034
- Market Representation: Revenue in $million and CAGR % from 2026 to 2034
- Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
- Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
- Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
- Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.
Qualitative Analysis:
- Industry Overview
- Industry Trends
- Market Driver, Restraints, and Opportunities
- Market Size
- Growth Trends
- Market Profitability Analysis
- Market Attractiveness Matrix
- Competitive Landscape
- Company Overview
- Financial Performance
- Product Portfolio
- Strategic Insights
- Recent Developments
Quantitative Analysis:
- Market Size Projections: Comprehensive estimates and forecasts for all segments
- Regional Market Analysis: Estimates and forecasts for key countries
- Corporate Financial Performance: Analysis of company financials
- Competitive Landscape: Market share analysis of leading companies
For inquiries regarding discounts on single or bundled report purchases, please reach out to us.
- Introduction
- Executive Summary
- Market Size Estimation ($million, 2024-2034)
- Forecast Estimation ($million and CAGR%, 2026-2034)
- Research Methodology
- Market Landscape
- Market Dynamics
- Drivers
- Barriers
- Opportunities
- Market Share Analysis
- Companies
- Products
- Market Trends Analysis
- Key success factors
- Market Growth Rate
- Market Attractiveness Analysis
- Market Profitability Analysis
- Buyer power
- Supplier power
- Barriers to entry
- Threat of substitute products
- Rivalry among firms in the industry
- Distribution Channels
- Market Dynamics
- Market Segmentation [refer Market Segments and Companies Tab]
- Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
- Source Type
- Reagents and Consumables Type
- Diagnostic Test
- Indication Type
- Technology
- Diagnostics, Therapeutic or Surgical Application
- End User Groups
- Geography (Region, Country)
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Latin America (Brazil, Mexico, Rest of LA)
- Rest of the World (Middle East & Africa)
- Company Profiles [refer Market Segments and Companies Tab]
- Company Overview
- Financial Snapshot
- Product Portfolio
- Business Strategies
- Recent Developments
- Recommendations
- References
Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What is the product or procedure volumes by country and regions?
Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)
CRISPR Therapeutics Market
1. Technology Type
1.1. CRISPR-Cas9 Gene Editing
1.2. Base Editing
1.3. Prime Editing
1.4. CRISPR Interference and Activation
1.5. Epigenome Editing
2. Application
2.1. Hemoglobinopathies
2.2. Oncology
2.3. Infectious Diseases
2.4. Metabolic Disorders
2.5. Ophthalmic Disorders
3. End User
3.1. Hospitals and Specialty Clinics
3.2. Academic and Research Institutions
3.3. Pharmaceutical and Biotechnology Companies
4. Geography
4.1. North America (U.S., Canada)
4.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.3. Asia Pacific (Japan, China, India, Rest of APAC)
4.4. Latin America (Brazil, Mexico, Rest of LA)
4.5. Rest of the World
5. Company Profiles
5.1. CRISPR Therapeutics AG
5.2. Editas Medicine, Inc.
5.3. Intellia Therapeutics, Inc.
5.4. Beam Therapeutics Inc.
5.5. Caribou Biosciences, Inc.
5.6. Mammoth Biosciences, Inc.
5.7. Vertex Pharmaceuticals Incorporated
5.8. Novartis AG
5.9. Regeneron Pharmaceuticals, Inc.
5.10. Eli Lilly and Company
Related Reports
-

Polymerase Chain Reaction Market and Forecast 2026-2034
$3,000.00 -

Cell Surface Markers Market and Forecast 2026-2034
$3,000.00 -

Life Science Reagents Market and Forecast 2026-2034
$3,000.00 -

Bioinformatics Market and Forecast 2026-2034
$3,000.00 -

Molecular Diagnostics Market and Forecast 2026-2034
$3,000.00 -

Computational Biology Market and Forecast 2026-2034
$3,000.00 -

Biosensors Market and Forecast 2026-2034
$3,000.00 -

Biopreservation Market and Forecast 2026-2034
$3,000.00